Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan

Kan Nakamura, MD, Eiji Kawasaki, MD, Akihisa Imagawa, MD, Takuya Awata, MD, Hiroshi Ikegami, MD, Yasuko Uchigata, MD, Tetsuro Kobayashi, MD, Akira Shimada, MD, Koji Nakanishi, MD, Hideichi Makino, MD, Taro Maruyama, MD, Toshiaki Hanafusa, MD, the Research Committee on Type 1 Diabetes of the Japan Diabetes Society

Diabetes Care 2011;34(9):2084–2089

https://doi.org/10.2337/dc10-2274

Published: 19 August 2011

View article titled, Type 1 Diabetes and Interferon Therapy: <subtitle>A nationwide survey in Japan</subtitle>

Includes: Supplementary data

Journal Articles

High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes: Response to Buzzetti et al.

Tetsuro Kobayashi, MD, PHD, Shoichiro Tanaka, MD, PHD, Akira Shimada, MD, PHD, Taro Maruyama, MD, PHD

Diabetes Care 2007;30(11):e126

https://doi.org/10.2337/dc07-1104

Published: 01 November 2007

View article titled, High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes: <subtitle>Response to Buzzetti et al.</subtitle>

Journal Articles

Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA_1c Levels at Onset

Shoichiro Tanaka, MD, Toyoshi Endo, MD, PHD, Kaoru Aida, MD, PHD, Hiroki Shimura, MD, PHD, Norihiko Yokomori, MD, PHD, Masahiro Kaneshige, MD, PHD, Fumihiko Furuya, MD, PHD, Shin Amemiya, MD, PHD, Mie Mochizuki, MD, PHD, Koji Nakanishi, MD, PHD, Tetsuro Kobayashi, MD, PHD

Diabetes Care 2004;27(8):1936–1941

https://doi.org/10.2337/diacare.27.8.1936

Published: 01 August 2004

View article titled, Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA<sub>1c</sub> Levels at Onset

Journal Articles

Fulminant Type 1 Diabetes: A nationwide survey in Japan

Akihisa Imagawa, MD, Toshiaki Hanafusa, MD, Yasuko Uchigata, MD, Azuma Kanatsuka, MD, Eiji Kawasaki, MD, Tetsuro Kobayashi, MD, Akira Shimada, MD, Ikki Shimizu, MD, Tetsuya Toyoda, MD, Taro Maruyama, MD, Hideichi Makino, MD

Diabetes Care 2003;26(8):2345–2352

https://doi.org/10.2337/diacare.26.8.2345

Published: 01 August 2003

View article titled, Fulminant Type 1 Diabetes: <subtitle>A nationwide survey in Japan</subtitle>

Journal Articles

Association of HLA-DQ Genotype in Autoantibody-Negative and Rapid-Onset Type 1 Diabetes

Shoichiro Tanaka, MD, Tetsuro Kobayashi, MD, Koji Nakanishi, MD, Rikako Koyama, MD, Minoru Okubo, MD, Toshio Murase, MD, Masato Odawara, MD, Hidetoshi Inoko, MD

Diabetes Care 2002;25(12):2302–2307

https://doi.org/10.2337/diacare.25.12.2302

Published: 01 December 2002

View article titled, Association of HLA-DQ Genotype in Autoantibody-Negative and Rapid-Onset Type 1 Diabetes

Journal Articles

Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis

Shoichiro Tanaka, MD, Tetsuro Kobayashi, MD, Koji Nakanishi, MD, Minoru Okubo, MD, Toshio Murase, MD, Masaji Hashimoto, MD, Goro Watanabe, MD, Hiroshi Matsushita, MD, Yuzo Endo, MD, Hideo Yoshizaki, MD, Tomoo Kosuge, MD, Michiie Sakamoto, MD, Kazuo Takeuchi, MD

Diabetes Care 2001;24(9):1661–1667

https://doi.org/10.2337/diacare.24.9.1661

Published: 01 September 2001

View article titled, Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis

Journal Articles

Slowly Progressive IDDM and Malnutrition-Related Diabetes

Koji Nakanishi, MD, Taka Matsumura, MD, Tetsuro Kobayashi, MD

Diabetes Care 1996;19(2):178

https://doi.org/10.2337/diacare.19.2.178a

Published: 01 February 1996

View article titled, Slowly Progressive IDDM and Malnutrition-Related Diabetes

Journal Articles

Prospective Study of Lipoprotein(a) as a Risk Factor for Atherosclerotic Cardiovascular Disease in Patients With Diabetes

Takaki Hiraga, MD, Tetsuro Kobayashi, MD, Minoru Okubo, MD, Kohji Nakanishi, MD, Tadao Sugimoto, MD, Yasuo Ohashi, PHD, Toshio Murase, MD

Diabetes Care 1995;18(2):241–244

https://doi.org/10.2337/diacare.18.2.241

Published: 01 February 1995

View article titled, Prospective Study of Lipoprotein(a) as a Risk Factor for Atherosclerotic Cardiovascular Disease in Patients With Diabetes

Journal Articles

Immunogenetic and Clinical Characterization of Slowly Progressive IDDM

Tetsuro Kobayashi, MD, Koji Tamemoto, MD, Koji Nakanishi, MD, Norihiro Kato, MD, Minoru Okubo, MD, Hiroshi Kajio, MD, Tadao Sugimoto, MD, Toshio Murase, MD, Kinori Kosaka, MD

Diabetes Care 1993;16(5):780–788

https://doi.org/10.2337/diacare.16.5.780

Published: 01 May 1993

View article titled, Immunogenetic and Clinical Characterization of Slowly Progressive IDDM

Journal Articles

Reply

Tetsuro Kobayashi, MD, Koji Nakanishi, MD, Toshio Murase, MD, Kinori Kosaka, MD

Diabetes Care 1992;15(10):1435–1436

https://doi.org/10.2337/diacare.15.10.1435b

Published: 01 October 1992

View article titled, Reply

Journal Articles

Maleness as Risk Factor for Slowly Progressive IDDM

Tetsuro Kobayashi, MD, Koji Nakanishi, MD, Tadao Sugimoto, MD, Tokuji Itoh, MD, Toshio Murase, MD, Kinori Kosaka, MD, Kimiyoshi Tsuji, MD

Diabetes Care 1989;12(1):7–11

https://doi.org/10.2337/diacare.12.1.7

Published: 01 January 1989

View article titled, Maleness as Risk Factor for Slowly Progressive IDDM

Journal Articles

Does Pan-Pancreatic Involvement Occur in IDDM?

Koji Nakanishi, MD, Tetsuro Kobayashi, MD, Tadao Sugimoto, MD, Toshio Murase, MD, Tokuji Itoh, MD, Kinori Kosaka, MD

Diabetes Care 1988;11(1):100–101

https://doi.org/10.2337/diacare.11.1.100

Published: 01 January 1988

View article titled, Does Pan-Pancreatic Involvement Occur in IDDM?

Journal Articles

Plasma Immunoreactive Somatostatin Response to Arginine After Glycemic Control With Continuous Subcutaneous Insulin Infusion in Type I Diabetics

Tetsuro Kobayashi, MD, Shinji Sawano, MD, Tokuji Itoh, MD, Kinori Kosaka, MD

Diabetes Care 1987;10(3):286–292

https://doi.org/10.2337/diacare.10.3.286

Published: 01 May 1987

View article titled, Plasma Immunoreactive Somatostatin Response to Arginine After Glycemic Control With Continuous Subcutaneous Insulin Infusion in Type I Diabetics

NARROW

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan

High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes: Response to Buzzetti et al.

Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA_1c Levels at Onset

Fulminant Type 1 Diabetes: A nationwide survey in Japan

Association of HLA-DQ Genotype in Autoantibody-Negative and Rapid-Onset Type 1 Diabetes

Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis

Slowly Progressive IDDM and Malnutrition-Related Diabetes

Prospective Study of Lipoprotein(a) as a Risk Factor for Atherosclerotic Cardiovascular Disease in Patients With Diabetes

Immunogenetic and Clinical Characterization of Slowly Progressive IDDM

Reply

Maleness as Risk Factor for Slowly Progressive IDDM

Does Pan-Pancreatic Involvement Occur in IDDM?

Plasma Immunoreactive Somatostatin Response to Arginine After Glycemic Control With Continuous Subcutaneous Insulin Infusion in Type I Diabetics

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only